Curis Competitors and Similar CompaniesClear all

Intrepida Bio's competitors and similar companies include MaxiVAX, Verseau Therapeutics and FoRx Therapeutics.
Intrepida Bio
Intrepida Bio
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.
MaxiVAX
MaxiVAX
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
Verseau Therapeutics
Verseau Therapeutics
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
FoRx Therapeutics
FoRx Therapeutics
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
Founding Date
Founding Date
2019
Founding Date
2013
Founding Date
2017
Founding Date
2019
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Genève, CH HQ
Genève, CH
Locations
Bedford, US HQ
Locations
Basel, CH HQ
Employees
Employees
N/A
Employees
5
Employees
6
Employees
343% increase

Funding

Latest funding round
Latest funding round
$ 9.5m (over 6 years ago)
Latest funding round
$ 5m (over 6 years ago)
Latest funding round
$ 50m (over 6 years ago)
Latest funding round
$ 10.8m (about 6 years ago)
Total funding raised
Total funding raised
$ 9.5m
Total funding raised
$ 8.1m
Total funding raised
$ 50m
Total funding raised
$ 10.8m
For sources of this data, please see the company profile

View Company Profiles

MaxiVAX
HQ
Genève, CH
Employees
5

MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.

View company
Verseau Therapeutics
HQ
Bedford, US
Employees
6

Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.

View company
FoRx Therapeutics
HQ
Basel, CH
Employees
34↑ 3% increase

FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.

View company